IPOPLUS

₹10.71

▼ -0.09 -0.83%

16 Jun 2026

BSE Listed

Gennex Laboratories Ltd. (531739)

Volume: 11,54,130Avg Vol 1W: 5,83,138Avg Vol 1M: 10,44,96152W Range:₹13.25₹29
BSE
Key Ratios
Updated 1h ago
Market Cap₹315 Cr
Current Price₹10.71
Previous Close₹10.8
High / Low (52w)₹29 / ₹13.25
Volume11,54,130
Avg Vol (1W)5,83,138
Avg Vol (1M)10,44,961
Stock P/E20.1
Book Value₹7.49
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B1.85
Debt / Equity—
50 DMA₹10.44
200 DMA₹12.07
Day change-0.83%
Price Chart
₹10.71▼ 14.32% · 1Y
₹17₹760.4L
2025-06-18
2026-06-16

20-day avg volume: 11.2L shares

Pros
  • Revenue grew 25% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue₹61 Cr₹40 Cr₹37 Cr₹34 Cr₹40 Cr—
EBITDA₹7 Cr₹8 Cr₹8 Cr₹7 Cr₹6 Cr—
Net Profit₹4 Cr₹5 Cr₹5 Cr₹5 Cr₹3 Cr—
EPS0.160.220.210.210.14—
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Revenue₹173 Cr₹138 Cr₹79 Cr₹65 Cr—
EBITDA₹31 Cr₹27 Cr₹22 Cr₹9 Cr—
Net Profit₹21 Cr₹18 Cr₹13 Cr₹5 Cr—
EPS0.760.780.610.32—
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Total Assets₹349 Cr₹256 Cr₹230 Cr₹132 Cr—
Total Liabilities₹116 Cr₹61 Cr₹54 Cr₹46 Cr—
Equity₹223 Cr₹187 Cr₹170 Cr₹80 Cr—
Total Debt₹79 Cr₹27 Cr₹19 Cr₹17 Cr—
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Operating₹-64 Cr₹-11 Cr₹-47 Cr₹24 Cr—
Investing₹-5 Cr₹1 Cr₹19 Cr₹-38 Cr—
Financing₹65 Cr₹5 Cr₹74 Cr₹21 Cr—
Free Cash Flow₹-76 Cr₹-20 Cr₹-47 Cr₹-16 Cr—

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search